Dendreon Biotechnology · Medical Research and Pharmaceutical Preparations · Pharmaceutical Preparations · Research and Development in the Physical, Engineering, and L · Pharmaceutical Preparation Manufacturing · Research & Development in Biotechnology
3005 1 Ave, Seattle, WA 98121 1301 2 Ave, Seattle, WA 98101 2062564545, 2062560571, 2068291500, 2068291622
David L Urdal
IMMUNEX CORPORATION
51 University St, Seattle, WA 98101 51 Univ St, Seattle, WA
David L Urdal Vice President
IMMUNEX OF WASHINGTON CORPORATION Pharmaceutical Sales · Nonclassifiable Establishments · Mfg & Mktg Therapeutic Pdts & Biotherapeutic Research
51 University St, Seattle, WA 98101 1 Amgen Ctr Dr, Newbury Park, CA 91320 PO Box 19027, Newbury Park, CA 91319 300 Deschutes Way SW STE 304 , Olympia, WA 98501 2063894019, 2064704180
David L. Urdal
VLST Corp Biotechnology · Commercial Physical Research
307 Westlake Ave N SUITE 300, Seattle, WA 98109 2062688550, 2062625544
The present invention provides monoclonal antibodies and binding proteins which specifically bind to the IL-1 receptor. Also provided are methods for detecting IL-1 receptors on cells, and for detecting soluble IL-1 receptors in serum.
Steven Dower - Redmond WA, US Carl March - Winslow WA, US John Sims - Seattle WA, US David Urdal - Seattle WA, US
International Classification:
A61K039/395 C07K016/24
US Classification:
424/145100, 530/388230
Abstract:
The present invention provides monoclonal antibodies and binding proteins which specifically bind to the IL-1 receptor. Also provided are methods for detecting IL-1 receptors on cells, and for detecting soluble IL-1 receptors in serum.
Steven K. Dower - Redmond WA Carl J. March - Seattle WA John E. Sims - Seattle WA David L. Urdal - Seattle WA
Assignee:
Immunex Corporation - Seattle WA
International Classification:
C07K 320
US Classification:
530413
Abstract:
Mammalian Interleukin-1 receptor proteins (IL-1Rs), DNAs and expression vectors encoding mammalian IL-1Rs, and processes for producing mammalian IL-1Rs as products of cell culture, including recombinant systems, are disclosed.
Method Of Using Soluble Human Interleukin-1 Receptors To Suppress Immune Responses
Steven K. Dower - Redmond WA Carl J. March - Seattle WA John E. Sims - Seattle WA David L. Urdal - Seattle WA
Assignee:
Immunex Corporation - Seattle WA
International Classification:
C12N 1500 C12N 1512 C12N 1211 C12N 06
US Classification:
435 691
Abstract:
Mammalian Interleukin-1 receptor proteins (IL-1Rs), DNAs and expression vectors encoding mammalian IL-1Rs, and processes for producing mammalian IL-1Rs as products of cell culture, including recombinant systems, are disclosed.
Steven K. Dower - Redmond WA Carl J. March - Winslow WA John Sims - Seattle WA David L. Urdal - Seattle WA
Assignee:
Immunex Corporation - Seattle WA
International Classification:
C07K 1300 A61K 3702
US Classification:
530350
Abstract:
Substantially purified and homogeneous soluble human interleukin-1 receptor (shuIL-1R) proteins, DNA encoding the shuIL-1R proteins and pharmaceutical compositions containing the shuIL-1R proteins are described.
Steven K. Dower - Redmond WA Carl J. March - Seattle WA John E. Sims - Seattle WA David L. Urdal - Seattle WA
Assignee:
Immunex Corporation - Seattle WA
International Classification:
C07K 1300 A61K 3702
US Classification:
530 351
Abstract:
Mammalian Interleukin-1 receptor proteins (IL-1Rs), DNAs and expression vectors encoding mammalian IL-1Rs, and processes for producing mammalian IL-1Rs as products of cell culture, including recombinant systems, are disclosed.
Youtube
PILOT: Cancer Immunotherapy (BioBusiness.TV O...
This pilot was produced with the financial support of Celldex Therapeu...